Article
September 14, 2016
Sanofi has appointed Dr. Frank Nestle as both the global head of immunology and inflammation research therapeutic area and North America chief scientific officer.
Based out of the French firm's Cambridge, MA office, Dr. Nestle will be responsible for developing Sanofi's early stage immunology and inflammations portfolio and driving its scientific intelligence across multiple therapeutic areas in the US.
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.